Measles [clinicaltrials_resource:4f846db8b6d8cc641a8af9a404efb4a7]
A Phase II, Comparative Study of Seroconversion of Single-Dose and Two-Dose Measles Vaccination in HIV-Infected and HIV-Uninfected Children: A Multicenter Trial of the Pediatric AIDS Clinical Trials Group [clinicaltrials:NCT00000815]Pneumococcal Vaccine and Routine Pediatric Immunizations in HIV-Infected Children Receiving Anti-HIV Drugs [clinicaltrials:NCT00013871]A Study of An Approved Vaccine at Mumps Expiry Potency in Healthy Children 12 to 18 Months of Age (V205C-007)(COMPLETED) [clinicaltrials:NCT00092391]Safety, Tolerability, and Immunogenicity of an Investigational Vaccine With Recombinant Human Albumin (rHA) in Children 12 to 18 Months of Age (V205C-009)(COMPLETED) [clinicaltrials:NCT00092404]Study to Evaluate Frozen Versus Refrigerated MMRV (Combined Measles, Mumps, Rubella, and Varicella) Investigational Vaccine (V221-016) [clinicaltrials:NCT00092430]A Measles, Mumps, and Rubella Investigational Vaccine Trial (V205C-010)(COMPLETED) [clinicaltrials:NCT00109278]clinicaltrials:NCT00109343Immunogenicity and Safety of Combined Vaccine to Prevent Measles, Mumps, Rubella and Chickenpox Diseases [clinicaltrials:NCT00126997]Immunogenicity and Safety of a Combined Vaccine to Prevent Measles, Mumps, Rubella and Chickenpox Diseases [clinicaltrials:NCT00127010]Immunogenicity and Safety of a Combined Vaccine to Prevent Measles, Mumps, Rubella and Chickenpox Diseases [clinicaltrials:NCT00127023]Responses of Premature Infants to Measles-Mumps-Rubella (MMR) and Varicella Vaccines [clinicaltrials:NCT00138255]Prophylactic Antibiotics in Measles [clinicaltrials:NCT00168532]Immunology of Non-specific Effects of Vaccine [clinicaltrials:NCT00168545]clinicaltrials:NCT00168558Long-term Follow-up of Measles Antibodies [clinicaltrials:NCT00168571]Non-Specific Effects of Standard Titre Measles Vaccination [clinicaltrials:NCT00168662]Ontogeny of Measles Immunity in Infants [clinicaltrials:NCT00240916]Impact of HIV on Measles and Measles Immunisation [clinicaltrials:NCT00247091]Immune Responses to Two Dose Varivax +/- MMR-II [clinicaltrials:NCT00258726]Immunogenicity and Safety of Hepatitis A Vaccine Given at the Same Time of Measles, Mumps, Rubella Combined Vaccine [clinicaltrials:NCT00313950]clinicaltrials:NCT00326183Immunogenicity/Safety of Measles-Mumps-Rubella-Varicella Vaccine (MeMuRu-OKA): Using Two Different Administration Routes [clinicaltrials:NCT00351923]Immunogenicity, Safety of Measles-mumps-rubella-varicella Vaccine (MeMuRu-OKA) Compared to Priorix™ Given With Varilrix™ [clinicaltrials:NCT00352898]Immunogenicity, Safety of Measles-Mumps-Rubella-Varicella Vaccine (MeMuRu-OKA) Compared to Priorix™ Given With Varilrix™ [clinicaltrials:NCT00353288]clinicaltrials:NCT00384397Assess GSK Biologicals' MMR Vaccine (Priorix) When Given to Healthy Children at the Age of 12 to 18 Months in Singapore. [clinicaltrials:NCT00388440]ProQuad® Intramuscular vs Subcutaneous [clinicaltrials:NCT00402831]Long-term Follow-up on Immunogenicity & Safety of Measles-Mumps-Rubella-Varicella (MMRV) Combined Vaccine [clinicaltrials:NCT00406211]clinicaltrials:NCT00422292Immunogenicity and Safety Study of Proquad® and Infanrix® Hexa When Administered Concomitantly [clinicaltrials:NCT00432042]Immunogenicity and Safety of Concomitant Administration of MMR™ rHA and VARIVAX® by Intramuscular Versus Subcutaneous Route [clinicaltrials:NCT00432523]Safety Study of a Refrigerator-Stable Formulation of VARIVAX® [clinicaltrials:NCT00432731]Safety & Immunogenicity Study of Meningococcal Vaccine GSK134612 Given With Priorix-Tetra™ to 12-23 Month-Old Children [clinicaltrials:NCT00474266]clinicaltrials:NCT00483574Study of Post-Training Supports for Health Workers in Benin [clinicaltrials:NCT00510679]ProQuad® rHA Safety [clinicaltrials:NCT00560755]Comparative Study of Immunogenicity and Safety of a 2-Dose Regimen of ProQuad® Manufactured With rHA [clinicaltrials:NCT00566527]The Influence of Probiotics on the Immunologic Response to Vaccinations in Infants [clinicaltrials:NCT00645996]Immunogenicity & Safety Study of GSK Biologicals' Combined Measles-mumps-rubella-varicella Vaccine 208136 [clinicaltrials:NCT00751348]Measles Vaccine in Patients With Measles Virus-Positive, Advanced Non-Small Cell Lung Cancer [clinicaltrials:NCT00828022]
condition [clinicaltrials_vocabulary:condition]
A Phase II, Comparative Study of Seroconversion of Single-Dose and Two-Dose Measles Vaccination in HIV-Infected and HIV-Uninfected Children: A Multicenter Trial of the Pediatric AIDS Clinical Trials Group [clinicaltrials:NCT00000815]Study to Evaluate Frozen Versus Refrigerated MMRV (Combined Measles, Mumps, Rubella, and Varicella) Investigational Vaccine (V221-016) [clinicaltrials:NCT00092430]A Measles, Mumps, and Rubella Investigational Vaccine Trial (V205C-010)(COMPLETED) [clinicaltrials:NCT00109278]Immunogenicity and Safety of Combined Vaccine to Prevent Measles, Mumps, Rubella and Chickenpox Diseases [clinicaltrials:NCT00126997]Immunogenicity and Safety of a Combined Vaccine to Prevent Measles, Mumps, Rubella and Chickenpox Diseases [clinicaltrials:NCT00127010]Immunogenicity and Safety of a Combined Vaccine to Prevent Measles, Mumps, Rubella and Chickenpox Diseases [clinicaltrials:NCT00127023]Responses of Premature Infants to Measles-Mumps-Rubella (MMR) and Varicella Vaccines [clinicaltrials:NCT00138255]Prophylactic Antibiotics in Measles [clinicaltrials:NCT00168532]clinicaltrials:NCT00168558Long-term Follow-up of Measles Antibodies [clinicaltrials:NCT00168571]Non-Specific Effects of Standard Titre Measles Vaccination [clinicaltrials:NCT00168662]Ontogeny of Measles Immunity in Infants [clinicaltrials:NCT00240916]Impact of HIV on Measles and Measles Immunisation [clinicaltrials:NCT00247091]Immune Responses to Two Dose Varivax +/- MMR-II [clinicaltrials:NCT00258726]Immunogenicity and Safety of Hepatitis A Vaccine Given at the Same Time of Measles, Mumps, Rubella Combined Vaccine [clinicaltrials:NCT00313950]clinicaltrials:NCT00326183Immunogenicity/Safety of Measles-Mumps-Rubella-Varicella Vaccine (MeMuRu-OKA): Using Two Different Administration Routes [clinicaltrials:NCT00351923]Immunogenicity, Safety of Measles-mumps-rubella-varicella Vaccine (MeMuRu-OKA) Compared to Priorix™ Given With Varilrix™ [clinicaltrials:NCT00352898]Immunogenicity, Safety of Measles-Mumps-Rubella-Varicella Vaccine (MeMuRu-OKA) Compared to Priorix™ Given With Varilrix™ [clinicaltrials:NCT00353288]Assess GSK Biologicals' MMR Vaccine (Priorix) When Given to Healthy Children at the Age of 12 to 18 Months in Singapore. [clinicaltrials:NCT00388440]Long-term Follow-up on Immunogenicity & Safety of Measles-Mumps-Rubella-Varicella (MMRV) Combined Vaccine [clinicaltrials:NCT00406211]Immunogenicity and Safety Study of Proquad® and Infanrix® Hexa When Administered Concomitantly [clinicaltrials:NCT00432042]ProQuad® rHA Safety [clinicaltrials:NCT00560755]clinicaltrials:NCT00578175Immunogenicity & Safety Study of GSK Biologicals' Combined Measles-mumps-rubella-varicella Vaccine 208136 [clinicaltrials:NCT00751348]Measles Vaccine in Patients With Measles Virus-Positive, Advanced Non-Small Cell Lung Cancer [clinicaltrials:NCT00828022]clinicaltrials:NCT00839917Study to Evaluate Safety, Dose Response and Immunogenicity of the Measles Vaccine MVA mBN85B in Healthy Children Aged 6 Months to 6 Years [clinicaltrials:NCT00891007]Immunogenicity & Safety Study of GSK Biologicals' 208136 Vaccine Formulated With New Measles and Rubella Working Seeds [clinicaltrials:NCT00892775]clinicaltrials:NCT00962819Comparison of GSK Measles-mumps-rubella-varicella (MMRV) Vaccine Versus PriorixTM [clinicaltrials:NCT00969436]clinicaltrials:NCT00975507clinicaltrials:NCT00985153clinicaltrials:NCT00985166clinicaltrials:NCT00986232clinicaltrials:NCT01188343Making Decisions About the Measles-Mumps-Rubella Vaccine [clinicaltrials:NCT01369394]Additional Measles Vaccine at 4 Months of Age [clinicaltrials:NCT01486355]Immunogenicity and Safety Study of PriorixTetra™ When Co-administered With Conjugated MenC Vaccine in Healthy Children [clinicaltrials:NCT01506193]clinicaltrials:NCT01536405
condition browse [clinicaltrials_vocabulary:condition-browse]
A Phase II, Comparative Study of Seroconversion of Single-Dose and Two-Dose Measles Vaccination in HIV-Infected and HIV-Uninfected Children: A Multicenter Trial of the Pediatric AIDS Clinical Trials Group [clinicaltrials:NCT00000815]Study to Evaluate Frozen Versus Refrigerated MMRV (Combined Measles, Mumps, Rubella, and Varicella) Investigational Vaccine (V221-016) [clinicaltrials:NCT00092430]A Measles, Mumps, and Rubella Investigational Vaccine Trial (V205C-010)(COMPLETED) [clinicaltrials:NCT00109278]Immunogenicity and Safety of Combined Vaccine to Prevent Measles, Mumps, Rubella and Chickenpox Diseases [clinicaltrials:NCT00126997]Immunogenicity and Safety of a Combined Vaccine to Prevent Measles, Mumps, Rubella and Chickenpox Diseases [clinicaltrials:NCT00127010]Immunogenicity and Safety of a Combined Vaccine to Prevent Measles, Mumps, Rubella and Chickenpox Diseases [clinicaltrials:NCT00127023]Responses of Premature Infants to Measles-Mumps-Rubella (MMR) and Varicella Vaccines [clinicaltrials:NCT00138255]Prophylactic Antibiotics in Measles [clinicaltrials:NCT00168532]clinicaltrials:NCT00168558Long-term Follow-up of Measles Antibodies [clinicaltrials:NCT00168571]Non-Specific Effects of Standard Titre Measles Vaccination [clinicaltrials:NCT00168662]Ontogeny of Measles Immunity in Infants [clinicaltrials:NCT00240916]Impact of HIV on Measles and Measles Immunisation [clinicaltrials:NCT00247091]Immune Responses to Two Dose Varivax +/- MMR-II [clinicaltrials:NCT00258726]Immunogenicity and Safety of Hepatitis A Vaccine Given at the Same Time of Measles, Mumps, Rubella Combined Vaccine [clinicaltrials:NCT00313950]clinicaltrials:NCT00326183Immunogenicity/Safety of Measles-Mumps-Rubella-Varicella Vaccine (MeMuRu-OKA): Using Two Different Administration Routes [clinicaltrials:NCT00351923]Immunogenicity, Safety of Measles-mumps-rubella-varicella Vaccine (MeMuRu-OKA) Compared to Priorix™ Given With Varilrix™ [clinicaltrials:NCT00352898]Immunogenicity, Safety of Measles-Mumps-Rubella-Varicella Vaccine (MeMuRu-OKA) Compared to Priorix™ Given With Varilrix™ [clinicaltrials:NCT00353288]Assess GSK Biologicals' MMR Vaccine (Priorix) When Given to Healthy Children at the Age of 12 to 18 Months in Singapore. [clinicaltrials:NCT00388440]Long-term Follow-up on Immunogenicity & Safety of Measles-Mumps-Rubella-Varicella (MMRV) Combined Vaccine [clinicaltrials:NCT00406211]Immunogenicity and Safety Study of Proquad® and Infanrix® Hexa When Administered Concomitantly [clinicaltrials:NCT00432042]ProQuad® rHA Safety [clinicaltrials:NCT00560755]clinicaltrials:NCT00578175Immunogenicity & Safety Study of GSK Biologicals' Combined Measles-mumps-rubella-varicella Vaccine 208136 [clinicaltrials:NCT00751348]Measles Vaccine in Patients With Measles Virus-Positive, Advanced Non-Small Cell Lung Cancer [clinicaltrials:NCT00828022]clinicaltrials:NCT00839917Study to Evaluate Safety, Dose Response and Immunogenicity of the Measles Vaccine MVA mBN85B in Healthy Children Aged 6 Months to 6 Years [clinicaltrials:NCT00891007]Immunogenicity & Safety Study of GSK Biologicals' 208136 Vaccine Formulated With New Measles and Rubella Working Seeds [clinicaltrials:NCT00892775]clinicaltrials:NCT00962819Comparison of GSK Measles-mumps-rubella-varicella (MMRV) Vaccine Versus PriorixTM [clinicaltrials:NCT00969436]clinicaltrials:NCT00975507clinicaltrials:NCT00985153clinicaltrials:NCT00985166clinicaltrials:NCT00986232clinicaltrials:NCT01188343Making Decisions About the Measles-Mumps-Rubella Vaccine [clinicaltrials:NCT01369394]Additional Measles Vaccine at 4 Months of Age [clinicaltrials:NCT01486355]Immunogenicity and Safety Study of PriorixTetra™ When Co-administered With Conjugated MenC Vaccine in Healthy Children [clinicaltrials:NCT01506193]clinicaltrials:NCT01536405
condition mesh [clinicaltrials_vocabulary:condition-mesh]
Measles [clinicaltrials_resource:4f846db8b6d8cc641a8af9a404efb4a7]
Bio2RDF identifier
4f846db8b6d8cc641a8af9a404efb4a7
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:4f846db8b6d8cc641a8af9a404efb4a7
identifier
clinicaltrials_resource:4f846db8b6d8cc641a8af9a404efb4a7
title
Measles
@en
type
label
Measles [clinicaltrials_resource:4f846db8b6d8cc641a8af9a404efb4a7]
@en